Jim Simons
NSPR icon

Jim Simons’s InspireMD NSPR Stock Holding History

Jim Simons’s Portfolio NSPR Stock Details NSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.7K Buy
+17,609
New +$30K ﹤0.01% 3150
2025
Q2 		– Sell
-31,378
Closed -$84.4K – 3789
2025
Q1 		$84.4K Buy
31,378
+20,978
+202% +$59.4K ﹤0.01% 3221
2024
Q4 		$27.4K Buy
+10,400
New +$28K ﹤0.01% 3460
2024
Q3 		– Sell
-10,800
Closed -$26.9K – 3774
2024
Q2 		$26.9K Sell
10,800
-1,600
-13% -$3.75K ﹤0.01% 3354
2024
Q1 		$29K Sell
12,400
-2,600
-17% -$7.01K ﹤0.01% 3558
2023
Q4 		$42K Sell
15,000
-1,700
-10% -$4.89K ﹤0.01% 3481
2023
Q3 		$55K Buy
16,700
+2,500
+18% +$7.98K ﹤0.01% 3385
2023
Q2 		$36K Buy
+14,200
New +$22.6K ﹤0.01% 3671
2021
Q3 		– Sell
-81,263
Closed -$410K – 3723
2021
Q2 		$410K Sell
81,263
-127,238
-61% -$770K ﹤0.01% 3036
2021
Q1 		$2.1M Buy
208,501
+125,628
+152% +$1.5M ﹤0.01% 2194
2020
Q4 		$424K Buy
82,873
+73,163
+753% +$387K ﹤0.01% 2892
2020
Q3 		$46K Buy
9,710
+7,170
+282% +$45.5K ﹤0.01% 3283
2020
Q2 		$18K Buy
+2,540
New +$25.8K ﹤0.01% 3375
2019
Q1 		– Sell
-521
Closed -$62K – 3615
2018
Q4 		$62K Buy
521
+145
+39% +$23K ﹤0.01% 3274
2018
Q3 		$62K Buy
+376
New +$59.7K ﹤0.01% 3269
2018
Q1 		– Sell
-2
Closed -$8K – 3508
2017
Q4 		$8K Buy
+2
New +$16.6K ﹤0.01% 3302
2017
Q1 		– Sell
-4
Closed -$274K – 3349
2016
Q4 		$274K Buy
4
+1
+33% +$65.7K ﹤0.01% 2934
2016
Q3 		$158K Buy
+3
New +$311K ﹤0.01% 3108
2016
Q2 		– Hold
0
– – – 3218
2016
Q1 		– Hold
0
– – – 3260
2015
Q4 		– Hold
0
– – – 3125
2015
Q3 		– Hold
0
– – – 3031
2015
Q2 		– Hold
0
– – – 3074
2015
Q1 		– Hold
0
– – – 3115

Other funds holding NSPR

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Jim Simons's NSPR Position: Q1 2026 in Review

Jim Simons opened a new position in InspireMD (NSPR) in Q1 2026: 17,609 shares worth $28.7K. The stake represents ﹤0.01% of the portfolio and ranks #3150 among its holdings. This is a return to the name: Jim Simons previously reported a position in NSPR as recently as Q1 2025.

Jim Simons first reported a position in NSPR in Q3 2016 and has held it in 18 quarters since. The position peaked at $2.1M in Q1 2021. 35 funds tracked by Wall St. Rank hold NSPR as of Q1 2026.

  • Jim Simons held 17,609 shares of InspireMD worth $28.7K as of Q1 2026.
  • InspireMD was a new Jim Simons position in Q1 2026.
  • InspireMD made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #3150 holding.
  • Jim Simons first reported a position in InspireMD in Q3 2016 and has held it in 18 quarters since.
  • Jim Simons's InspireMD position peaked at $2.1M in Q1 2021.
  • 35 funds tracked by Wall St. Rank held InspireMD as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.